Cancer Immunotherapy and Nanobiotechnology: An Interdisciplinary Approach
The “Cancer Immunotherapy and Nanobiotechnology: An Interdisciplinary Approach” is the twenty fifth volume of the “Interdisciplinary Cancer Research” series, publishes comprehensive volume on cancer immunotherapy and nanobiotechnology. The volume starts with chapters on targeting mitochondria in can...
שמור ב:
| מחבר תאגידי: | |
|---|---|
| מחברים אחרים: | |
| פורמט: | אלקטרוני ספר אלקטרוני |
| שפה: | אנגלית |
| יצא לאור: |
Cham :
Springer Nature Switzerland : Imprint: Springer,
2025.
|
| מהדורה: | 1st ed. 2025. |
| סדרה: | Interdisciplinary Cancer Research,
25 |
| נושאים: | |
| גישה מקוונת: | https://doi.org/10.1007/978-3-032-03862-3 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
MARC
| LEADER | 00000nam a22000005i 4500 | ||
|---|---|---|---|
| 001 | 978-3-032-03862-3 | ||
| 003 | DE-He213 | ||
| 005 | 20260810160053.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 250818s2025 sz | o |||| 0|eng d | ||
| 020 | |a 9783032038623 |9 978-3-032-03862-3 | ||
| 024 | 7 | |a 10.1007/978-3-032-03862-3 |2 doi | |
| 050 | 4 | |a RC261-271 | |
| 072 | 7 | |a MJCL |2 bicssc | |
| 072 | 7 | |a MED062000 |2 bisacsh | |
| 072 | 7 | |a MJCL |2 thema | |
| 082 | 0 | 4 | |a 571.978 |2 23 |
| 082 | 0 | 4 | |a 616.994 |2 23 |
| 245 | 1 | 0 | |a Cancer Immunotherapy and Nanobiotechnology: An Interdisciplinary Approach |h [electronic resource] / |c edited by Nima Rezaei. |
| 250 | |a 1st ed. 2025. | ||
| 264 | 1 | |a Cham : |b Springer Nature Switzerland : |b Imprint: Springer, |c 2025. | |
| 300 | |a 1 online resource (XIII, 922 p. 111 illus.). |b 108 illus. in color. | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 341 | 0 | |b PDF/UA-1 |2 onix | |
| 341 | 0 | |b Table of contents navigation |2 onix | |
| 341 | 0 | |b Single logical reading order |2 onix | |
| 341 | 0 | |b Short alternative textual descriptions |2 onix | |
| 341 | 0 | |b Use of color is not sole means of conveying information |2 onix | |
| 341 | 0 | |b Use of high contrast between text and background color |2 onix | |
| 341 | 0 | |b Next / Previous structural navigation |2 onix | |
| 341 | 0 | |b All non-decorative content supports reading without sight |2 onix | |
| 347 | |a text file |b PDF |2 rda | ||
| 490 | 1 | |a Interdisciplinary Cancer Research, |x 2731-457X ; |v 25 | |
| 505 | 0 | |a Targeting Mitochondria in Cancer Immunotherapy; Promises and Pitfalls -- Immunotherapy in Oncology: A Comprehensive Overview from a Pathological Perspective -- Cancer Treatments through Immunological Pathways: A Great Hope for Every Cancer Type and Every Patient? -- Cancer Immunotherapies Targeting Cancer Stem Cells: Concepts, Applications, and Advances -- Immune Checkpoint Inhibitors: Novel Therapies and Targets -- Advancing Cancer Immune Cell Therapies via Engineered iPSC-based Strategies -- CAR NK/CAR T cells: Emerging Immunotherapy of Cancer -- Cytokine Release Syndrome in Chimeric Antigen Receptor T Cell Therapy and Coagulopathies -- The Power of Imaging Techniques in CAR T-Cell Therapy Enhancement: Revolutionizing Cancer Treatment -- Discovery of T cell Epitopes for Cancer Immunotherapy -- Dendritic Cells in Cancer Immunotherapy: Current State and Future Prospects -- Tumor Microenvironment Role in Cancer Immunotherapy Response -- T-cell Responses During Cancer Immunotherapy Through the Use of CT, MRI, and PET -- Nanotechnology for Cancer Research (Diagnosis & Therapy): Recent Progress and Future Prospects -- Nanotechnology and Cancer Therapy Strategies -- Nanomedicine based Cancer Immunotherapy -- Applications of Nanocarrier Systems in Cancer Treatment -- Nanoformulations in Cancer Theranostics -- The Role of Noble Metal Nanomaterials in Cancer Therapy -- Synthetic and Natural Drug Nanodelivery Systems Used in Oncology Treatment -- Nanoparticles Loaded with Cytotoxic Agents: A Therapeutic Alternative against Cancer -- Advancements in Nanocarrier-Mediated Drug Delivery: Precision Strategies for Targeted Therapeutics and Improved Treatment Outcomes -- Vesicular Nanosystem as a Promising Platform for the Management of Cancer -- Nanoscale Metal-Organic Frameworks for Cancer-Targeted Therapy and Molecular Imaging -- Theranostic Properties of Iron Oxide Nanoparticles and Their Reprograming Properties on Tumor-associated Macrophages -- Composition of Proapoptotic Montmorillonite-Cytochrome C Nanoplates with High Anticancer Cytotoxicity: Monolayer Adsorption Approach -- Nanomaterials as Modulators of Non-apoptotic Regulated Cell Death Modes: Novel Options in Cancer Treatment. | |
| 520 | |a The “Cancer Immunotherapy and Nanobiotechnology: An Interdisciplinary Approach” is the twenty fifth volume of the “Interdisciplinary Cancer Research” series, publishes comprehensive volume on cancer immunotherapy and nanobiotechnology. The volume starts with chapters on targeting mitochondria in cancer immunotherapy, immunotherapy in oncology, and cancer treatments through immunological pathways. Immune checkpoint inhibitors as well as engineered iPSC-based strategies are explained in other chapters after discussion on cancer stem cells. CAR NK, CAR T cells, and DC therapy are the subjects of the following chapters. Then tumor microenviroment in response to immunotherapy and T-cell responses during cancer immunotherapy through the use of imaging are explained. The second half of the volume is focused on application of nanobiotechnology in cancer, starting with general chapters on nanotechnology for cancer research, nanotechnology and cancer therapy strategies, nanomedicine based cancer immunotherapy, applications of nanocarrier systems in cancer treatment, and nanoformulations in cancer theranostics. Then the role of metal nanomaterials in cancer therapy, synthetic drug nanodelivery systems, nanoparticles loaded with cytotoxic agents, nanocarrier-mediated drug delivery, vesicular nanosystem, and nanoscale metal-organic frameworks for cancer-targeted therapy are explained. This is the main concept of Cancer Immunology Project (CIP), which is a part of Universal Scientific Education and Research Network (USERN). This interdisciplinary book will be of special value for those who wish to have an update on cancer immunotherapy and nanobiotechnology. | ||
| 532 | 8 | |a Accessibility summary: This PDF has been created in accordance with the PDF/UA-1 standard to enhance accessibility, including screen reader support, described non-text content (images, graphs), bookmarks for easy navigation, keyboard-friendly links and forms and searchable, selectable text. We recognize the importance of accessibility, and we welcome queries about accessibility for any of our products. If you have a question or an access need, please get in touch with us at accessibilitysupport@springernature.com. Please note that a more accessible version of this eBook is available as ePub. | |
| 532 | 8 | |a No reading system accessibility options actively disabled | |
| 532 | 8 | |a Publisher contact for further accessibility information: accessibilitysupport@springernature.com | |
| 588 | |a Print version record. | ||
| 650 | 0 | |a Cancer. | |
| 650 | 0 | |a Cancer |x Treatment. | |
| 650 | 0 | |a Stem cells. | |
| 650 | 0 | |a Cytology. | |
| 650 | 0 | |a Medical genetics. | |
| 650 | 0 | |a Immunology. | |
| 650 | 1 | 4 | |a Cancer Biology. |
| 650 | 2 | 4 | |a Cancer Therapy. |
| 650 | 2 | 4 | |a Cancer Stem Cells. |
| 650 | 2 | 4 | |a Cell Biology. |
| 650 | 2 | 4 | |a Medical Genetics. |
| 650 | 2 | 4 | |a Immunology. |
| 700 | 1 | |a Rezaei, Nima. |e editor. |0 (orcid)0000-0002-3836-1827 |1 https://orcid.org/0000-0002-3836-1827 |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 710 | 2 | |a SpringerLink (Online service) | |
| 773 | 0 | |t Springer Nature eBook | |
| 776 | 0 | 8 | |i Printed edition: |z 9783032038616 |
| 776 | 0 | 8 | |i Printed edition: |z 9783032038630 |
| 776 | 0 | 8 | |i Printed edition: |z 9783032038647 |
| 830 | 0 | |a Interdisciplinary Cancer Research, |x 2731-457X ; |v 25 | |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-3-032-03862-3 |
| 912 | |a ZDB-2-SBL | ||
| 912 | |a ZDB-2-SXB | ||
| 912 | |a ZDB-2-237 | ||
| 950 | |a Biomedical and Life Sciences (SpringerNature-11642) | ||
| 950 | |a Biomedical and Life Sciences (R0) (SpringerNature-43708) | ||
| 950 | |a Focus Bundle Biomedical and Human Health Sciences (SpringerNature-85407) | ||